Results 61 to 70 of about 4,279 (197)
Vancomycin‐Functionalized Nanodelivery Systems for Antibacterial Tissue Engineering Scaffolds
Advanced NanoBiomed Research, Volume 6, Issue 1, January 2026.This review consolidates recent advancements in VAN nanoformulations, critically evaluating their design principles, release mechanisms, and efficacy profiles against resistant Gram‐positive pathogens. While promising in vitro and in vivo results have been demonstrated, the clinicaltranslation of these technologies necessitates further rigorous ...
Nima Beheshtizadeh +5 more
wiley +1 more source
In vitro activity of Tedizolid and Dalbavancin against MRSA strains is dependent on infection source
International Journal of Infectious Diseases, 2019 Objective: We tested the in vitro susceptibility to Tedizolid and Dalbavancin of Methicillin-resistant Staphylococcus aureus strains recovered from blood and wound cultures, and compared our results with studies conducted in the last four years.
Maya Azrad +4 more
doaj +1 more source
Annals of Clinical Microbiology and Antimicrobials, 2022 Background Dalbavancin is a semisynthetic antibiotic used as an alternative to vancomycin for skin infections and osteomyelitis. Its long half-life decreases length of hospitalizations.
Connor Evins +2 more
doaj +1 more source
A focus on the newer antibiotics targeting Gram-positive bacteria [PDF]
, 2007 The incidence of antimicrobial resistance has continued to rise with a threat to return to the “pre-antibiotic” era. This has included a sharp increase in multi-drug resistant organisms, which may cause life-threatening infections. Efforts have been made
Cuschieri, Paul +2 more
core
Pathogens of skin and skin-structure infections in the UK and their susceptibility to antibiotics, including ceftaroline [PDF]
, 2015 Objectives: Bacterial skin and skin-structure infections (SSSIs) are frequent settings for antibiotic use. We surveyed their UK aetiology and pathogen susceptibility, including susceptibility to ceftaroline.
James, Dorothy +5 more
core +1 more source
Prosthetic Mitral Valve Endocarditis due to Vagococcus fluvialis: A Case Report
Case Reports in Medicine, Volume 2026, Issue 1, 2026.Infective endocarditis (IE) is an uncommon but life‐threatening disease, most frequently caused by Staphylococcus aureus, streptococci, and enterococci. Vagococcus fluvialis is a Gram‐stain positive coccus, phenotypically close to enterococci, and rarely identified in human infections due to diagnostic challenges.
Camille Le Guillou +9 more
wiley +1 more source
Microbiology Spectrum, 2023 Dalbavancin is a second-generation lipoglycopeptide antibiotic with activity against Gram-positive organisms. Dalbavancin is Food and Drug Administration (FDA)-approved for acute bacterial skin and soft tissue infections (ABSSTIs).
Richard Lueking +4 more
doaj +1 more source
An Uncommon Presentation of Sweet’s Syndrome in Primary Myelofibrosis
Case Reports in Hematology, Volume 2026, Issue 1, 2026.Sweet’s syndrome (SS) is a rare neutrophilic dermatosis often associated with hematologic malignancies. Due to its infectious mimicry, diagnosis is frequently delayed. We report a case of primary myelofibrosis initially treated for suspected cellulitis, which progressed to necrotic lesions and refractory fever despite broad‐spectrum antibiotics. A skin
Valentina Rago +7 more
wiley +1 more source
AAPS Open, 2023 Heat stress studies have been conducted in support of developing a heat-stable liquid solution of dalbavancin. The degradation products that form in heat-stressed buffered dalbavancin solutions have been identified, including the known major degradation ...
Sardar M. Jakaria +2 more
doaj +1 more source
Global shortage of neonatal and paediatric antibiotic trials: rapid review. [PDF]
, 2017 OBJECTIVES: There have been few clinical trials (CTs) on antibiotics that inform neonatal and paediatric drug labelling. The rate of unlicensed and off-label prescribing in paediatrics remains high.
Barker, CI +6 more
core +4 more sources